0001062993-23-020478.txt : 20231113
0001062993-23-020478.hdr.sgml : 20231113
20231113063117
ACCESSION NUMBER: 0001062993-23-020478
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231107
FILED AS OF DATE: 20231113
DATE AS OF CHANGE: 20231113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clarke Dorothy J
CENTRAL INDEX KEY: 0001992152
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41403
FILM NUMBER: 231394883
MAIL ADDRESS:
STREET 1: C/O ETERNA THERAPEUTICS INC.
STREET 2: 1035 CAMBRIDGE STREET, STE. 18A
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc.
CENTRAL INDEX KEY: 0001907685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 874706968
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (617)871-2101
MAIL ADDRESS:
STREET 1: 12 GILL STREET
STREET 2: SUITE 4650
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-11-07
0001907685
Comera Life Sciences Holdings, Inc.
CMRA
0001992152
Clarke Dorothy J
C/O COMERA LIFE SCIENCES HOLDINGS, INC.
12 GILL STREET, SUITE 4650
WOBURN
MA
01801
1
0
0
0
0
Stock Option (Right to Purchase
0.355
2023-11-07
4
A
0
14200
0
A
2033-11-07
Common Stock
14200
14200
D
Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The stock option shall vest over three (3) years, with one-third of the shares of common stock underlying the option vesting on November 7, 2024, and the remainder vesting in equal monthly installments thereafter.
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
2023-11-09